ICU Medical ROA 2006-2018 | ICUI

Current and historical return on assets (ROA) values for ICU Medical (ICUI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. ICU Medical ROA for the three months ending December 31, 2018 was 10.85%.
ICU Medical ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-12-31 $0.03B $1.59B 1.89%
2018-09-30 $0.09B $1.55B 5.68%
2018-06-30 $0.09B $1.53B 5.70%
2018-03-31 $0.02B $1.49B 1.20%
2017-12-31 $0.07B $1.50B 4.62%
2017-09-30 $0.03B $1.52B 2.24%
2017-06-30 $0.05B $1.49B 4.41%
2017-03-31 $0.10B $1.47B 11.56%
2016-12-31 $0.06B $0.71B 9.51%
2016-09-30 $0.06B $0.69B 9.02%
2016-06-30 $0.06B $0.66B 8.83%
2016-03-31 $0.05B $0.64B 8.68%
2015-12-31 $0.05B $0.63B 7.62%
2015-09-30 $0.05B $0.61B 8.26%
2015-06-30 $0.04B $0.57B 6.75%
2015-03-31 $0.03B $0.55B 5.41%
2014-12-31 $0.03B $0.54B 4.96%
2014-09-30 $0.03B $0.53B 6.23%
2014-06-30 $0.04B $0.52B 7.42%
2014-03-31 $0.04B $0.51B 7.89%
2013-12-31 $0.04B $0.50B 8.61%
2013-09-30 $0.04B $0.47B 8.72%
2013-06-30 $0.04B $0.45B 9.24%
2013-03-31 $0.04B $0.44B 10.04%
2012-12-31 $0.04B $0.43B 10.18%
2012-09-30 $0.05B $0.41B 12.18%
2012-06-30 $0.04B $0.39B 11.94%
2012-03-31 $0.04B $0.38B 12.33%
2011-12-31 $0.04B $0.36B 12.75%
2011-09-30 $0.04B $0.34B 10.53%
2011-06-30 $0.04B $0.35B 10.89%
2011-03-31 $0.03B $0.33B 11.09%
2010-12-31 $0.03B $0.31B 10.14%
2010-09-30 $0.03B $0.30B 9.13%
2010-06-30 $0.02B $0.29B 8.05%
2010-03-31 $0.02B $0.29B 7.30%
2009-12-31 $0.03B $0.31B 8.25%
2009-09-30 $0.03B $0.31B 9.44%
2009-06-30 $0.03B $0.30B 10.47%
2009-03-31 $0.03B $0.29B 10.48%
2008-12-31 $0.03B $0.28B 9.43%
2008-09-30 $0.02B $0.27B 8.63%
2008-06-30 $0.02B $0.26B 7.62%
2008-03-31 $0.02B $0.25B 6.84%
2007-12-31 $0.02B $0.24B 9.64%
2007-09-30 $0.03B $0.25B 10.03%
2007-06-30 $0.03B $0.26B 10.55%
2007-03-31 $0.03B $0.25B 12.12%
2006-12-31 $0.03B $0.24B 10.83%
2006-09-30 $0.02B $0.24B 10.41%
2006-06-30 $0.02B $0.23B 10.95%
2006-03-31 $0.02B $0.22B 11.03%
2005-12-31 $0.02B $0.21B 10.58%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $4.771B $1.400B
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.272B 27.73
Medtronic (MDT) Ireland $125.787B 18.39
Stryker (SYK) United States $72.312B 26.54
Boston Scientific (BSX) United States $55.730B 27.17
Baxter (BAX) United States $39.435B 25.23
Zimmer Biomet Holdings (ZBH) United States $25.742B 16.48
Smith & Nephew SNATS (SNN) United Kingdom $17.346B 0.00
Canopy Growth (CGC) Canada $15.357B 0.00
ResMed (RMD) United States $14.383B 27.27
Aurora Cannabis (ACB) Canada $9.728B 68.64
Bio-Rad Laboratories (BIO) United States $9.298B 53.05
Hill-Rom Holdings (HRC) United States $6.949B 21.49
Perrigo (PRGO) Ireland $6.542B 10.61
Insulet (PODD) United States $5.812B 1960.80
GW Pharmaceuticals (GWPH) United Kingdom $5.107B 0.00
Haemonetics (HAE) United States $4.422B 39.23
Agios Pharmaceuticals (AGIO) United States $3.796B 0.00
Hutchison China MediTech (HCM) China $3.712B 0.00
Neogen (NEOG) United States $3.240B 49.77
NuVasive (NUVA) United States $2.859B 24.94
Quidel (QDEL) United States $2.688B 24.25
Aphria (APHA) $2.403B 106.67
National Vision Holdings (EYE) United States $2.385B 46.92
Cardiovascular Systems (CSII) United States $1.382B 992.25
Phibro Animal Health (PAHC) United States $1.275B 18.33
VAREX IMAGING (VREX) United States $1.255B 24.57
AtriCure (ATRC) United States $1.121B 0.00
MacroGenics (MGNX) United States $0.933B 0.00
Lantheus Holdings (LNTH) United States $0.929B 25.10
NanoString Technologies (NSTG) United States $0.855B 0.00
Cerus (CERS) United States $0.838B 0.00
PetIQ (PETQ) United States $0.787B 22.53
Omeros (OMER) United States $0.786B 0.00
OraSure Technologies (OSUR) United States $0.721B 31.62
Surmodics (SRDX) United States $0.703B 102.18
Meridian Bioscience (VIVO) United States $0.701B 20.89
Evolus (EOLS) United States $0.677B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.655B 22.28
LeMaitre Vascular (LMAT) United States $0.614B 29.22
TG Therapeutics (TGTX) United States $0.607B 0.00
Quanterix (QTRX) United States $0.552B 0.00
BioLife Solutions (BLFS) United States $0.346B 143.85
Vapotherm (VAPO) United States $0.335B 0.00
Utah Medical Products (UTMD) United States $0.323B 21.01
Insys Therapeutics (INSY) United States $0.308B 0.00
Owens & Minor (OMI) United States $0.301B 4.17
Rockwell Medical (RMTI) United States $0.297B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.269B 0.00
Bovie Medical (APYX) United States $0.263B 0.00
Cytosorbents (CTSO) United States $0.255B 0.00
Fonar (FONR) United States $0.146B 7.81
Zynex (ZYXI) United States $0.142B 15.14
Surface Oncology (SURF) United States $0.131B 0.00
Chimerix (CMRX) United States $0.104B 0.00
Chembio Diagnostics (CEMI) United States $0.101B 0.00
Female Health (VERU) United States $0.094B 0.00
United-Guardian (UG) United States $0.089B 18.64
Conatus Pharmaceuticals (CNAT) United States $0.081B 0.00
Trinity Biotech (TRIB) Ireland $0.073B 21.79
CAS Medical Systems (CASM) United States $0.072B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Neurotrope (NTRP) United States $0.052B 0.00
Valeritas Holdings (VLRX) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Senestech (SNES) United States $0.026B 0.00
Capricor Therapeutics (CAPR) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.14